Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects
- PMID: 19042931
- PMCID: PMC2677792
- DOI: 10.1093/brain/awn320
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects
Abstract
Although beta-amyloid (Abeta) plaques are a primary diagnostic criterion for Alzheimer's disease, this pathology is commonly observed in the brains of non-demented older individuals. To explore the importance of this pathology in the absence of dementia, we compared levels of amyloid deposition (via 'Pittsburgh Compound-B' (PIB) positron emission tomography (PET) imaging) to hippocampus volume (HV) and episodic memory (EM) in three groups: (i) normal controls (NC) from the Berkeley Aging Cohort (BAC NC, n = 20); (ii) normal controls (NC) from the Alzheimer's disease neuroimaging initiative (ADNI NC, n = 17); and (iii) PIB+ mild cognitive impairment subjects from the ADNI (ADNI PIB+ MCI, n = 39). Age, gender and education were controlled for in each statistical model, and HV was adjusted for intracranial volume (aHV). In BAC NC, elevated PIB uptake was significantly associated with smaller aHV (P = 0.0016) and worse EM (P = 0.0086). Within ADNI NC, elevated PIB uptake was significantly associated with smaller aHV (P = 0.047) but not EM (P = 0.60); within ADNI PIB+ MCI, elevated PIB uptake was significantly associated with both smaller aHV (P = 0.00070) and worse EM (P = 0.046). To further understand these relationships, a recursive regression procedure was conducted within all ADNI NC and PIB+ MCI subjects (n = 56) to test the hypothesis that HV mediates the relationship between Abeta and EM. Significant correlations were found between PIB index and EM (P = 0.0044), PIB index and aHV (P < 0.0001), as well as between aHV and EM (P < 0.0001). When both aHV and PIB were included in the same model to predict EM, aHV remained significant (P = 0.0015) whereas PIB index was no longer significantly associated with EM (P = 0.50). These results are consistent with a model in which Abeta deposition, hippocampal atrophy, and EM occur sequentially in elderly subjects, with Abeta deposition as the primary event in this cascade. This pattern suggests that declining EM in older individuals may be caused by Abeta-induced hippocampus atrophy.
Figures








Similar articles
-
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.JAMA Neurol. 2013 Jul;70(7):903-11. doi: 10.1001/jamaneurol.2013.1062. JAMA Neurol. 2013. PMID: 23712469
-
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.Brain. 2009 May;132(Pt 5):1355-65. doi: 10.1093/brain/awp062. Epub 2009 Mar 31. Brain. 2009. PMID: 19339253 Free PMC article.
-
Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration.J Neurosci Res. 2021 Feb;99(2):481-501. doi: 10.1002/jnr.24739. Epub 2020 Oct 18. J Neurosci Res. 2021. PMID: 33073383
-
Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease.Neurodegener Dis. 2012;10(1-4):141-4. doi: 10.1159/000334295. Epub 2012 Feb 1. Neurodegener Dis. 2012. PMID: 22301812 Review.
-
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Semin Nucl Med. 2011. PMID: 21624562 Review.
Cited by
-
Alzheimer brain-derived amyloid β-protein impairs synaptic remodeling and memory consolidation.Neurobiol Aging. 2013 May;34(5):1315-27. doi: 10.1016/j.neurobiolaging.2012.10.028. Epub 2012 Nov 22. Neurobiol Aging. 2013. PMID: 23182244 Free PMC article.
-
Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.PLoS One. 2015 Jul 29;10(7):e0123743. doi: 10.1371/journal.pone.0123743. eCollection 2015. PLoS One. 2015. PMID: 26221954 Free PMC article. Clinical Trial.
-
Dynamic multilayer functional connectivity detects preclinical and clinical Alzheimer's disease.Cereb Cortex. 2024 Jan 31;34(2):bhad542. doi: 10.1093/cercor/bhad542. Cereb Cortex. 2024. PMID: 38212285 Free PMC article.
-
Unraveling the complexity of human brain: Structure, function in healthy and disease states.Ageing Res Rev. 2024 Sep;100:102414. doi: 10.1016/j.arr.2024.102414. Epub 2024 Jul 15. Ageing Res Rev. 2024. PMID: 39002647 Review.
-
Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.Neuroimage. 2013 May 1;71:207-15. doi: 10.1016/j.neuroimage.2013.01.015. Epub 2013 Jan 24. Neuroimage. 2013. PMID: 23353602 Free PMC article.
References
-
- Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol. 2006;63:693–9. - PubMed
-
- Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex. 1991;1:103–16. - PubMed
-
- Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173–82. - PubMed
-
- Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66:1837–44. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG027859/AG/NIA NIH HHS/United States
- P30 AG019610/AG/NIA NIH HHS/United States
- R01 AG027859-02/AG/NIA NIH HHS/United States
- R01 AG034570/AG/NIA NIH HHS/United States
- P50 AG023501/AG/NIA NIH HHS/United States
- AG024904/AG/NIA NIH HHS/United States
- R01 AG027342/AG/NIA NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- U19 AG010483/AG/NIA NIH HHS/United States
- K23 AG031861/AG/NIA NIH HHS/United States
- AG027859/AG/NIA NIH HHS/United States
- G0601846/MRC_/Medical Research Council/United Kingdom
- P01 AG010491-14/AG/NIA NIH HHS/United States
- P01 AG010491/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical